2014 Newcomb Cleveland Prize Honors Discovery of the Brain’s Glymphatic System

Research that has transformed scientists’ understanding of the brain and neurodegenerative diseases like Alzheimer’s has been awarded the 2014 Newcomb Cleveland Prize of the American Association for the Advancement of Science (AAAS).

The Association’s oldest honor, the prize annually recognizes the author or authors of an outstanding paper published in the journal Science, and will be awarded this year for a study that appeared in the October 2013 edition of journal, entitled “Sleep Drives Metabolite Clearance from the Adult Brain.” The prize will be presented on Friday, February 13, at the AAAS Annual Meeting in San Jose, California.

Read more

Norwest’s iCardiac Seeks to Be Game-Changer with New Cardiac Safety Test

Amy Or, Wall Street Journal, 17 December 2014

Norwest Venture Partners’ portfolio company iCardiac Technologies Inc. may have a way to help pharmaceutical companies detect which experimental drugs might flat line over cardiac concerns.

The Rochester, N.Y.-based company recently completed a study in collaboration with the U.S. Food and Drug Administration which demonstrated that cardiac toxicity in drugs can be detected much earlier in the development process than previously thought by medical professionals.

Read the complete article here.